# OnCo record timothy-hughes (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/timothy-hughes/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "timothy-hughes" ;
  schema:name "Timothy P. Hughes"@en ;
  schema:description "Defined molecular response monitoring in CML and showed that many patients can safely stop imatinib."@en ;
  schema:url <https://onco.cc/people/timothy-hughes/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Hughes%20TP%5BAuthor%5D%20chronic%20myeloid%20leukemia> ;
  onco:tag "cml", "molecular-monitoring", "australia" ;
  schema:jobTitle "Consultant Haematologist, Royal Adelaide Hospital; Cancer Theme Leader, South Australian Health and Medical Research Institute" ;
  onco:cancers <https://onco.cc/cancers/cml/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/imatinib/> ;
  onco:institutions <https://onco.cc/institutions/royal-adelaide-hospital/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-iris-imatinib-nejm-2003/> ;
  schema:affiliation <https://onco.cc/institutions/royal-adelaide-hospital/> .